GLP-1 drugs, such as Wegovy and Ozempic, are gaining popularity in the US and Europe for their appetite-suppressing ...

Joey Gonzalez, global co-CEO of Barry’s, joins CNBC to discuss outlooks on fitness in the era of GLP-1 drugs, trends in gym ...

Zoe co-founder Tim Spector warned that a prime opportunity is going to waste even for those using weight loss jabs ...

Benefits advisors today are navigating a complex pharmacy benefits market with many opaque practices and hidden pitfalls.

Wasatch Global Investors, an asset management company, released its “Wasatch Small Cap Growth Strategy” third-quarter 2024 ...